Literature DB >> 12077046

Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs.

Simon J C Davies1, Leila B Cooke, Alan G Moore, John Potokar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077046      PMCID: PMC1123452          DOI: 10.1136/bmj.324.7352.1519

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients.

Authors:  J G Reilly; S A Ayis; I N Ferrier; S J Jones; S H Thomas
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

2.  A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland.

Authors:  O P Mehtonen; K Aranko; L Mälkonen; H Vapaatalo
Journal:  Acta Psychiatr Scand       Date:  1991-07       Impact factor: 6.392

3.  Controlled study of pimozide vs. placebo in Tourette's syndrome.

Authors:  A K Shapiro; E Shapiro
Journal:  J Am Acad Child Psychiatry       Date:  1984-03

Review 4.  Mortality from neuroleptic malignant syndrome.

Authors:  A Shalev; H Hermesh; H Munitz
Journal:  J Clin Psychiatry       Date:  1989-01       Impact factor: 4.384

5.  Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.

Authors:  K Hartigan-Go; D N Bateman; G Nyberg; E Mårtensson; S H Thomas
Journal:  Clin Pharmacol Ther       Date:  1996-11       Impact factor: 6.875

  5 in total
  6 in total

1.  Discontinuation of thioridazine. Risks must be balanced.

Authors:  Ann F Bisset
Journal:  BMJ       Date:  2002-10-26

2.  Effects of licence change on prescribing and poisons enquiries for antipsychotic agents in England and Scotland.

Authors:  D N Bateman; A M Good; R Afshari; C A Kelly
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

3.  Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single-dose thioridazine in young volunteers.

Authors:  Miroslav Ravic; Steve Warrington; Malcolm Boyce; Kate Dunn; Atholl Johnston
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

4.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

5.  Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning.

Authors:  E M Strachan; C A Kelly; D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  2004-09-15       Impact factor: 2.953

6.  Potential for drug interactions involving cytochromes P450 2D6 and 3A4 on general adult psychiatric and functional elderly psychiatric wards.

Authors:  S J C Davies; S Eayrs; P Pratt; M S Lennard
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.